Mechanism of Action of Beta-Blocking Agents in Heart Failure
- 1 December 1997
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 80 (11) , 26L-40L
- https://doi.org/10.1016/s0002-9149(97)00846-1
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized studyJournal of the American College of Cardiology, 1995
- Basal and Isoprenaline-Stimulated cAMP Content in Failing Versus Nonfailing Human Cardiac PreparationsJournal of Cardiovascular Pharmacology, 1989
- Subsensitivity of the Failing Human Heart to Isoprenaline and Milrinoneo is Related to β-Adrenoceptor DownregulationJournal of Cardiovascular Pharmacology, 1988
- Reversibility of Catecholamine-Induced Dilated Cardiomyopathy in a Child with a PheochromocytomaNew England Journal of Medicine, 1987
- Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.Circulation, 1985
- The Adrenergic Nervous System in Heart FailureNew England Journal of Medicine, 1984
- Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.Circulation, 1983
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981